| 1st consultation | D0 | D7 to D12 | D13 | D14 | D15 | D16 | D17 | D19 | D21 | D24 | D44 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | POD1 | POD2 | POD3 | POD5 | POD7 | POD10 | POD30 |
General data | ||||||||||||
First Name | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Last Name | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Sexe | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Date of birthday | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Phone number | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Adress | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Center | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Medical history and comorbidity | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Concomittant medication | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Preoperative chemotherapy | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
History of liver surgery | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ASA score | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Date of 1st consultation | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Operating date | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â |
Type of liver resection | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â |
Preoperative protein-energy malnutrition | ||||||||||||
Height | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Actual weight | x | Â | Â | x | Â | Â | Â | Â | Â | Â | x | x |
BMI | x | Â | Â | x | Â | Â | Â | Â | Â | Â | x | x |
Usual weight | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
% of loss of weight in one and 6Â months | x | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Albumin, prealbumin | Â | x | Â | x | Â | Â | Â | Â | Â | Â | Â | Â |
MNA-SF (for patients > 70 years old) | x |  |  |  |  |  |  |  |  |  |  |  |
Sarcopenia (Psoas area on CT scan) | Â | x | Â | Â | Â | Â | x | Â | Â | Â | x | x |
Compliance to immunonutrition treatment | ||||||||||||
Nutritional journal | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â |
Liver function assessment | ||||||||||||
PT, INR | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
AST, ALT | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
GGT, PAL | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
Total and direct bilirubin | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
Platelets | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
Volumetric assessment of (future) remnant liver | x | Â | Â | Â | Â | Â | x | Â | Â | Â | x | x |
Renal function assessment | ||||||||||||
Creatinine, urea | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
Sodium, potassium | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
Hemoglobin | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
White cells, lymphocytes | Â | x | Â | x | Â | x | Â | x | x | x | x | x |
Follow up | ||||||||||||
Overall morbidity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x |
Infectious complications | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x |
Biliary leak | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x |
Length of hospital and ICU stay | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x |
Length of antibiotic treatment | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | x |